Search
Binge Eating Paid Clinical Trials in Missouri
A listing of 1 Binge Eating clinical trials in Missouri actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 1 of 1
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Binge Eating
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
The state of Missouri currently has 1 active clinical trials seeking participants for Binge Eating research studies. These trials are conducted in various cities, including Saint Louis, Kansas City, St. Louis and Springfield.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Binge Eating Disorder Clinical Study
Recruiting
Adults living with binge eating disorder could be eligible for a research study evaluating a potential new investigational medication for binge eating disorder. Get paid to help advance critical research.
Conditions:
Binge-Eating Disorder
Binge Eating Disorder
Binge Eating
Obesity
Overweight and Obesity
Featured Trial
Binge Eating Disorder Clinical Study
Recruiting
Adults living with binge eating disorder could be eligible for a research study evaluating a potential new investigational medication for binge eating disorder. Get paid to help advance critical research.
Conditions:
Binge-Eating Disorder
Binge Eating Disorder
Binge Eating
Obesity
Overweight and Obesity
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Naltrexone Neuroimaging in Teens with Eating Disorders
Recruiting
Using a randomized, placebo-controlled, crossover study, this study will evaluate functional magnetic resonance imaging (fMRI) as a pharmacodynamic biomarker of opioid antagonism in adolescents with eating disorders. The hypothesis is that fMRI will be able to detect acute reward pathway modulation by naltrexone (an opioid antagonist) in pre-defined regions of interest (anterior cingulate cortex, nucleus accumbens, dorsolateral prefrontal cortex).
Gender:
ALL
Ages:
Between 13 years and 21 years
Trial Updated:
11/01/2024
Locations: Children's Mercy Research Institute, Kansas City, Missouri
Conditions: Eating Disorders, Binge Eating, Purging (Eating Disorders), Bulimia Nervosa, Anorexia Nervosa, Atypical
1 - 1 of 1